Table 1. Comparison of the reactivity with peptide NTM1 of sera from cancer patients, athletes and healthy control subjects.
Tested population | Number of subjects | Gender | O.D. (mean) | O.D. (± s.d.) |
Cancer patients | ||||
Breast cancer | 15 | F | 0.021 | 0.011 |
Prostate cancer | 17 | M | 0.022 | 0.014 |
Athletes | ||||
Swimming | 7 | F | 0.269 | 0.074 |
Water polo | 8 | F | 0.171 | 0.105 |
Volleyball | 13 | F | 0.104 | 0.033 |
Rowing | 8 | M | 0.131 | 0.046 |
Wrestling | 9 | M | 0.106 | 0.054 |
Karate | 9 | M | 0.108 | 0.020 |
Controls | ||||
17 | F | 0.041 | 0.025 | |
17 | M | 0.046 | 0.016 |